Skye Bioscience
SKYE
#9927
Rank
ยฃ29.09 M
Marketcap
ยฃ0.91
Share price
0.83%
Change (1 day)
-70.71%
Change (1 year)

Revenue for Skye Bioscience (SKYE)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Skye Bioscience from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A-100%
2014 ยฃ0.09 M-55.97%
2013 ยฃ0.2 M362.53%
2012 ยฃ0.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA